Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
2 |
21/06/24 |
21/06/24 |
Charts
|
33K
|
16M
|
2
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
0 |
21/06/24 |
21/06/24 |
Charts
|
33K
|
16M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
Blinger
|
199 |
71K |
0 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
199
|
71K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
1
|
|
Property
|
|
Re:
Capital Growth
|
|
Blinger
|
136 |
22K |
4 |
19/06/24 |
19/06/24 |
Property
|
136
|
22K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
Property
|
|
Re:
Capital Growth
|
|
Blinger
|
136 |
22K |
2 |
19/06/24 |
19/06/24 |
Property
|
136
|
22K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
Property
|
|
Re:
Capital Growth
|
|
Blinger
|
136 |
22K |
3 |
19/06/24 |
19/06/24 |
Property
|
136
|
22K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
1
|
|
Property
|
|
Re:
Capital Growth
|
|
Blinger
|
136 |
22K |
3 |
19/06/24 |
19/06/24 |
Property
|
136
|
22K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
5
|
|
Property
|
|
Re:
Capital Growth
|
|
Blinger
|
136 |
22K |
2 |
19/06/24 |
19/06/24 |
Property
|
136
|
22K
|
2
|
|
ASX - By Stock
|
RXL |
Re:
Instos back the Youanmi Gold Project
|
|
Blinger
|
47 |
13K |
4 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
47
|
13K
|
4
|
|
Property
|
|
Re:
Capital Growth
|
|
Blinger
|
136 |
22K |
1 |
18/06/24 |
18/06/24 |
Property
|
136
|
22K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
2 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
2
|
|
ASX - By Stock
|
AUN |
Re:
Ann: DRILLING HITS 18m @ 25.8g/t Au AT PLUM PUDDING
|
|
Blinger
|
35 |
13K |
6 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
35
|
13K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
5 |
18/06/24 |
18/06/24 |
Charts
|
33K
|
16M
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
8 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
609
|
105K
|
8
|
|
ASX - By Stock
|
RXL |
Re:
Instos back the Youanmi Gold Project
|
|
Blinger
|
47 |
13K |
2 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
47
|
13K
|
2
|
|
ASX - By Stock
|
AUN |
Re:
Ann: DRILLING HITS 18m @ 25.8g/t Au AT PLUM PUDDING
|
|
Blinger
|
35 |
13K |
1 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
35
|
13K
|
1
|
|
ASX - By Stock
|
AUN |
Re:
Ann: DRILLING HITS 18m @ 25.8g/t Au AT PLUM PUDDING
|
|
Blinger
|
35 |
13K |
0 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
35
|
13K
|
0
|
|
ASX - By Stock
|
RXL |
Re:
Instos back the Youanmi Gold Project
|
|
Blinger
|
47 |
13K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
47
|
13K
|
3
|
|
ASX - By Stock
|
RXL |
Re:
Instos back the Youanmi Gold Project
|
|
Blinger
|
47 |
13K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
47
|
13K
|
3
|
|
ASX - By Stock
|
RXL |
Re:
Instos back the Youanmi Gold Project
|
|
Blinger
|
47 |
13K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
47
|
13K
|
3
|
|
ASX - By Stock
|
RXL |
Re:
Instos back the Youanmi Gold Project
|
|
Blinger
|
47 |
13K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
47
|
13K
|
3
|
|
ASX - By Stock
|
RXL |
Re:
Instos back the Youanmi Gold Project
|
|
Blinger
|
47 |
13K |
2 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
47
|
13K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
5 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
4 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Blinger
|
225 |
81K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
225
|
81K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Blinger
|
225 |
81K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
225
|
81K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
1 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
1 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
4 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
Blinger
|
225 |
81K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
225
|
81K
|
0
|
|
ASX - By Stock
|
RXL |
Re:
Instos back the Youanmi Gold Project
|
|
Blinger
|
47 |
13K |
7 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
47
|
13K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
1 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|